Cue Biopharma, Inc. (CUE) DCF Valuation

Cue Biopharma, Inc. (CUE) DCF Valuation

US | Healthcare | Biotechnology | NASDAQ
Cue Biopharma, Inc. (CUE) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

Cue Biopharma, Inc. (CUE) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore the financial future of Cue Biopharma, Inc. (CUE) with our user-friendly DCF Calculator! Enter your assumptions regarding growth, margins, and costs to calculate Cue Biopharma's intrinsic value and refine your investment approach.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 3.5 3.2 14.9 1.2 5.5 6.9 8.6 10.7 13.4 16.7
Revenue Growth, % 0 -8.78 373.68 -91.67 340.88 24.89 24.89 24.89 24.89 24.89
EBITDA -36.0 -44.0 -45.4 -50.5 -46.1 -6.9 -8.6 -10.7 -13.4 -16.7
EBITDA, % -1039.86 -1394.44 -304.15 -4054.72 -838.83 -100 -100 -100 -100 -100
Depreciation 5.4 1.1 -1.8 1.8 3.4 3.9 4.9 6.1 7.6 9.5
Depreciation, % 154.85 33.52 -11.9 145.04 62.59 56.84 56.84 56.84 56.84 56.84
EBIT -41.3 -45.0 -43.7 -52.3 -49.5 -6.9 -8.6 -10.7 -13.4 -16.7
EBIT, % -1194.72 -1427.96 -292.25 -4199.76 -901.42 -100 -100 -100 -100 -100
Total Cash 44.3 84.9 64.4 76.3 48.5 6.9 8.6 10.7 13.4 16.7
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .8 1.4 3.1 .1 1.7
Account Receivables, % 21.83 44.94 21.03 4.6 30.93
Inventories 15.1 .0 .0 .0 .0 1.4 1.7 2.1 2.7 3.3
Inventories, % 437.25 0 0.000006692827 0.000080306643 0 20 20 20 20 20
Accounts Payable .9 2.1 2.6 2.7 3.5 3.7 4.7 5.8 7.3 9.1
Accounts Payable, % 25.53 65.63 17.34 219.32 63.77 54.45 54.45 54.45 54.45 54.45
Capital Expenditure .0 -.6 -.9 -.2 .0 -.5 -.7 -.9 -1.1 -1.3
Capital Expenditure, % -1.34 -18.87 -6.11 -13.71 0 -8.01 -8.01 -8.01 -8.01 -8.01
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -41.8 -45.3 -44.2 -52.1 -49.5 -6.9 -8.6 -10.7 -13.3 -16.7
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -51.5 -29.1 -48.1 -47.2 -46.9 -4.6 -4.2 -5.3 -6.6 -8.2
WACC, % 11.88 11.88 11.88 11.87 11.88 11.87 11.87 11.87 11.87 11.87
PV UFCF
SUM PV UFCF -20.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -8
Terminal Value -85
Present Terminal Value -48
Enterprise Value -68
Net Debt -34
Equity Value -35
Diluted Shares Outstanding, MM 46
Equity Value Per Share -0.76

What You Will Get

  • Comprehensive CUE Financials: Access to historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
  • Scenario Analysis: Explore various scenarios to assess Cue Biopharma's future performance.
  • User-Friendly Design: Designed for professionals while remaining approachable for newcomers.

Key Features

  • Comprehensive Data Access: Cue Biopharma's historical financial records and pre-filled projections.
  • Customizable Parameters: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Insights: View Cue Biopharma's intrinsic value update instantly.
  • Intuitive Visualizations: Dashboard graphs illustrate valuation outcomes and essential metrics.
  • Designed for Precision: A reliable tool for analysts, investors, and finance professionals.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based CUE DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and more.
  3. Instant Calculations: The model automatically updates Cue Biopharma’s intrinsic value.
  4. Test Scenarios: Experiment with different assumptions to assess potential valuation changes.
  5. Analyze and Decide: Utilize the results to inform your investment or financial analysis.

Why Choose This Calculator?

  • Accurate Data: Real Cue Biopharma financials ensure reliable valuation results.
  • Customizable: Adjust key parameters like growth rates, WACC, and tax rates to align with your projections.
  • Time-Saving: Pre-built calculations save you from starting from scratch.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants.
  • User-Friendly: Intuitive design and step-by-step guidance make it accessible for all users.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Cue Biopharma, Inc. (CUE) stock.
  • Financial Analysts: Enhance valuation processes with comprehensive financial models tailored for Cue Biopharma, Inc. (CUE).
  • Consultants: Provide clients with expert valuation insights on Cue Biopharma, Inc. (CUE) quickly and accurately.
  • Business Owners: Gain insights into how biopharmaceutical companies like Cue Biopharma, Inc. (CUE) are valued to inform your own business strategies.
  • Finance Students: Explore valuation techniques using real-world data and scenarios related to Cue Biopharma, Inc. (CUE).

What the Template Contains

  • Historical Data: Includes Cue Biopharma’s past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Cue Biopharma’s intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Cue Biopharma’s financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.